GP1BA and Thrombocytopenia: Therefore, in the anti-GPIbα IgG-treated mice, it is possible that a subsequent increase in platelet count is influencing subsequent events, although given the propensity for platelet surfaces to passivate over time, this seems less likely than an effect of the initial thrombocytopenia.